The safety of remdesivir for COVID-19 patients

被引:2
|
作者
Chen, Hsien-Lin [1 ]
Chao, Chien-Ming [2 ]
Lai, Chih-Cheng [3 ]
机构
[1] Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan
[2] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan
[3] Kaohsiung Vet Gen Hosp, Dept Internal Med, Tainan Branch, 427 Fuxing Rd, Tainan 710, Taiwan
关键词
antiviral agents; disease control; SARS coronavirus; toxicity; virus classification;
D O I
10.1002/jmv.26735
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:1910 / 1912
页数:3
相关论文
共 50 条
  • [1] Remdesivir for patients with COVID-19
    Wu, Peter E.
    Morris, Andrew M.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (04) : E125 - E125
  • [2] Remdesivir for patients with COVID-19
    Wu, Peter E.
    Morris, Andrew M.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (14) : E495 - E496
  • [3] Remdesivir for Patients with COVID-19
    Augustin, M.
    Hallek, M.
    Nitschmann, S.
    [J]. INTERNIST, 2020, 61 (08): : 869 - 872
  • [4] Efficacy and Safety of Remdesivir in COVID-19 Positive Dialysis Patients
    Butt, Batool
    Hussain, Tajamul
    Jarrar, Mu'taman
    Khalid, Kashaf
    Albaker, Waleed
    Ambreen, Asma
    Waheed, Yasir
    [J]. ANTIBIOTICS-BASEL, 2022, 11 (02):
  • [5] Clinical Effectiveness and Safety of Remdesivir in Hemodialysis Patients with COVID-19
    Lim, Jeong-Hoo
    Park, Sang Don
    Jeon, Yena
    Chung, Yu Kyung
    Kwon, Jae Wan
    Jeon, You Hyun
    Jung, Hee-Yeon
    Park, Sun-Hee
    Kim, Chan-Duck
    Kim, Yong-Lim
    Kwon, Ki Tae
    Choi, Ji-Young
    Cho, Jang-Hee
    [J]. KIDNEY INTERNATIONAL REPORTS, 2022, 7 (11): : 2522 - 2525
  • [6] Use of Remdesivir in Patients With COVID-19 on Hemodialysis: A Study of Safety and Tolerance
    Aiswarya, Dhanapalan
    Arumugam, Venkatesh
    Dineshkumar, Thanigachalam
    Gopalakrishnan, Natarajan
    Lamech, Tanuj Moses
    Nithya, Govindasamy
    Sastry, Bhagavatula V. R. H.
    Vathsalyan, Paulpandian
    Dhanapriya, Jeyachandran
    Sakthirajan, Ramanathan
    [J]. KIDNEY INTERNATIONAL REPORTS, 2021, 6 (03): : 586 - 593
  • [7] Safety outcomes of Remdesivir for treatment of COVID-19 hospitalised patients in Indonesia
    Hasmono, Didik
    Samirah, Samirah
    Hartono, Ruddy
    Subkhan, Mohammad
    Yoshida, Maria Angelia
    Leliga, Fenny Kesuma
    [J]. PHARMACY EDUCATION, 2024, 24 (03): : 348 - 352
  • [8] Clinical safety of remdesivir therapy in COVID-19 patients with renal insufficiency
    Park, Somi
    Kim, A. Reum
    Lee, Jiyoung
    Kang, Sung-Woon
    Sung, Heungsup
    Kim, Mi-Na
    Chang, Euijin
    Bae, Seongman
    Jung, Jiwon
    Kim, Min Jae
    Kim, Sung -Han
    Choi, Sang -Ho
    Kim, Yang Soo
    Song, Eun Hee
    Chong, Yong Pil
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (04) : 366 - 370
  • [9] Remdesivir for patients with severe COVID-19
    Augustin, M.
    Hallek, M.
    Nitschmann, S.
    [J]. INTERNIST, 2020, 61 (06): : 644 - 645
  • [10] Safety and heart rate changes in Covid-19 patients treated with Remdesivir
    Brunetti, Natale Daniele
    Poliseno, Mariacristina
    Bottalico, Irene Francesca
    Centola, Antonio
    Montemurro, Laura
    Sica, Salvatore
    Santantonio, Teresa
    Lo Caputo, Sergio
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 112 : 254 - 257